Cover Image

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis

Saved in:

Bibliographic Details
Main Authors:	Virginia De Rose (Author), Pierre-Régis Burgel (Author), Amit Gaggar (Author), Catherine Greene (Author)
Format:	Book
Published:	Hindawi Limited, 2018-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Airway Epithelium Dysfunction in Cystic Fibrosis and COPD
by: Virginia De Rose, et al.
Published: (2018)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
by: Bergin DA, et al.
Published: (2013)

New Developments in Cystic Fibrosis Airway Inflammation
by: Nades Palaniyar, et al.
Published: (2015)

MicroRNA Dysregulation in Cystic Fibrosis
by: Paul J. McKiernan, et al.
Published: (2015)

Three-Dimensional Airway Spheroids and Organoids for Cystic Fibrosis Research
by: Onofrio Laselva, et al.
Published: (2021)

Enhancing Cystic Fibrosis Immune Regulation
by: Anna M. van Heeckeren, et al.
Published: (2021)

Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
by: Andrew Berical, et al.
Published: (2019)

The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease
by: Maelle Briottet, et al.
Published: (2020)

Free DNA in Cystic Fibrosis Airway Fluids Correlates with Airflow Obstruction
by: Veronica Marcos, et al.
Published: (2015)

Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study
by: M. Olszowiec-Chlebna, et al.
Published: (2019)

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis
by: Montemari AL, et al.
Published: (2022)

Th1/17-Biased Inflammatory Environment Associated with COPD Alters the Response of Airway Epithelial Cells to Viral and Bacterial Stimuli
by: Yifan Chen, et al.
Published: (2019)

Inhibition of Toll-Like Receptor 2-Mediated Interleukin-8 Production in Cystic Fibrosis Airway Epithelial Cells via the α7-Nicotinic Acetylcholine Receptor
by: Catherine M. Greene, et al.
Published: (2010)

Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects
by: Qi Y, et al.
Published: (2024)

Editorial: Real-world experience with CFTR modulator therapy
by: Burkhard Tümmler, et al.
Published: (2023)

Esomeprazole Increases Airway Surface Liquid pH in Primary Cystic Fibrosis Epithelial Cells
by: Livia Delpiano, et al.
Published: (2018)

Assessment of the microbial load of airway clearance devices used by a cohort of children with cystic fibrosis
by: B. Linnane, et al.
Published: (2021)

Neutrophil extracellular traps and the dysfunctional innate immune response of cystic fibrosis lung disease: a review
by: Sheonagh M. Law, et al.
Published: (2017)

CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
by: Katherine B. Hisert, et al.
Published: (2020)

Inflammation and Immune Response in COPD: Where Do We Stand?
by: Nikoletta Rovina, et al.
Published: (2013)

Airway Smooth Muscle Regulated by Oxidative Stress in COPD
by: Hiroaki Kume, et al.
Published: (2023)

Simulation of Airway Deposition of an Aerosol Drug in COPD Patients
by: Árpád Farkas, et al.
Published: (2019)

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i>
by: Emma Reece, et al.
Published: (2021)

Association between occupational exposure and the clinical characteristics of COPD
by: Caillaud Denis, et al.
Published: (2012)

Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
by: Lucy Perrem, et al.
Published: (2020)

Potential of anti-inflammatory treatment for cystic fibrosis lung disease
by: Jennifer L Taylor-Cousar, et al.
Published: (2010)

Mitochondrial Stress Responses and "Mito-Inflammation" in Cystic Fibrosis
by: Simone Patergnani, et al.
Published: (2020)

Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
by: Elisabetta Teopompi, et al.
Published: (2019)

Ruthenium(II) Polypyridyl Complexes for Antimicrobial Photodynamic Therapy: Prospects for Application in Cystic Fibrosis Lung Airways
by: Raphaëlle Youf, et al.
Published: (2022)

Genetic Deletion and Pharmacological Inhibition of PI3Kγ Reduces Neutrophilic Airway Inflammation and Lung Damage in Mice with Cystic Fibrosis-Like Lung Disease
by: Maria Galluzzo, et al.
Published: (2015)

Inflammatory Markers in Cystic Fibrosis Patients with Lung Pseudomonas Aeruginosa Infection
by: A. L. Pukhalsky, et al.
Published: (1999)

Transcriptional consequences of impaired immune cell responses induced by cystic fibrosis plasma characterized via dual RNA sequencing
by: Justin E. Ideozu, et al.
Published: (2019)

Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy
by: Ulrike Müller, et al.
Published: (2015)

Effects of cannabis oil extract on immune response gene expression in human small airway epithelial cells (HSAEpC): implications for chronic obstructive pulmonary disease (COPD)
by: Stephen W. Mamber, et al.
Published: (2020)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
by: Schmidt BZ, et al.
Published: (2016)

The History of Cystic Fibrosis
by: Javier Pérez-Frías, et al.
Published: (2019)

Vasculitis in Cystic Fibrosis
by: Francesca Sposito, et al.
Published: (2020)

ASTHMA IN CYSTIC FIBROSIS
by: Marcela Daniela Ionescu, et al.
Published: (2015)

Inflammation in Cystic Fibrosis
Published: (1996)

Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorticosteroids
by: Hiroaki Kume, et al.
Published: (2019)